Navigation Links
Mylan Confirms First-to-File Patent Challenge Relating to Orapred ODT®
Date:12/17/2010

PITTSBURGH, Dec. 17, 2010 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc. have been sued by Shionogi Pharma Inc. and CIMA LABS INC. in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Prednisolone Sodium Phosphate Orally Disintegrating Tablets, 10 mg, 15 mg and 30 mg. This product is the generic version of Orapred ODT®, a corticosteroid indicated as an anti-inflammatory or immunosuppressive agent for the treatment of certain endocrine conditions and for palliation of certain neoplastic conditions.

Mylan believes it is the first company to have filed a substantially complete ANDA containing a Paragraph IV certification for the 10 mg, 15 mg and 30 mg strengths and expects to qualify for 180 days of marketing exclusivity upon final FDA approval. Shionogi Pharma and CIMA LABS filed the lawsuit in the U.S. District Court for the District of Delaware.

Orapred ODT had U.S. sales of approximately $28 million for the 12 months ending Sept. 30, 2010, according to IMS Health. Currently, Mylan has 164 ANDAs pending FDA approval representing $98.9 billion in annual sales, according to IMS Health. Forty-five of these pending ANDAs are potential first-to-file opportunities, representing $24 billion in annual brand sales, for the 12 months ending June 30, 2010, according to IMS Health.

This press release includes statements that constitute "forward-looking statements," including with regard to the expected first-to-file status and pending litigation. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Because such statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward
'/>"/>

SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Mylan Receives Approval for Generic Version of Adalat® CC Tablets
2. Mylan Announces the Conversion of its Preferred Stock into Common Stock
3. Mylan Announces Final Conversion Rate for Mandatory Convertible Preferred Stock
4. Third Circuit Denies Mylan Motion for Interim Injunction
5. Mylan Reports Adjusted Diluted EPS of $0.43; Reaffirms 2010 Adjusted Diluted EPS Guidance of $1.55 - $1.65
6. Mylan Declares Quarterly Preferred Stock Dividend
7. Mylan to Appeal Court Decision in Generic Paroxetine Hydrochloride CR Case
8. Mylan Receives Approvals for Generic Versions of Hyzaar® and Cozaar®
9. Delcath Signs Agreement With Synerx and Mylans Bioniche Teoranta for Melphalan Supply
10. Mylan Receives Approval for Fludarabine Phosphate Injection, USP
11. Mylan Launches Generic Version of Wellbutrin XL® Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 17, 2014  NuView Life Sciences, Inc. (NuView) ... collaboration agreement with Otsuka Pharmaceutical Co., Ltd. (Otsuka) ... diagnostic biomarker to detect cancers of the breast ... future diagnostic-imaging applications. NuView retains all rights for ... in-vitro urine screen applications. Under the ...
(Date:9/17/2014)... Calif. , Sept. 17, 2014 ... announced that it has earned a $4 million ... AKAO ) associated with the initiation of a ... serious multi-drug resistant (MDR), gram-negative bacterial infections.  The ... study to evaluate the efficacy and safety of ...
(Date:9/17/2014)...  Trovagene, Inc., (NASDAQ:   TROV) a developer of ... , Ph.D., has joined the Company,s Scientific Advisory Board. ... in the kinase genes that are associated with colorectal ... Department of Oncology, Torino Medical School, Institute for Cancer ... "Alberto,s work in cancer genomics has had ...
Breaking Medicine Technology:NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 2NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 3NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 4NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 5Isis Pharmaceuticals Earns $4 Million from Achaogen for the Initiation of a Phase 3 Study of Plazomicin 2Isis Pharmaceuticals Earns $4 Million from Achaogen for the Initiation of a Phase 3 Study of Plazomicin 3Cancer Geneticist, Alberto Bardelli, Ph.D., Joins Trovagene's Scientific Advisory Board 2Cancer Geneticist, Alberto Bardelli, Ph.D., Joins Trovagene's Scientific Advisory Board 3
... global provider of advanced analytical instruments for laboratories and ... MultiTek(TM) testing system for the fast, accurate detection of ... include BioFuels, Chemicals, Food & Beverage, Manufacturing and Assembly, ... is the only instrument on the market that combines ...
... personalized medicine advances will create therapies that are so effective, ... to gain access, the inventor of the DNA gene sequencer ... Personalized Health Care National Conference . , ... said personalized medicine,s first "killer apps" - therapies that will ...
Cached Medicine Technology:New ANTEK MultiTek(TM) by PAC Provides Fast, All-in-One Testing for Sulfur, Nitrogen, Halides 2Personalized Medicine 'Killer Apps' Will Transform Care Model 2
(Date:9/17/2014)... Dr. Shervin Naderi, MD, FACS, one of the ... recipient of the 2014 Vitals Top 10 Doctor Award. This ... as it honors physicians that have earned the highest patient ... by his plastic surgeon colleagues as “The Nose Man,” is ... surgeons in the world. He is the founder of ...
(Date:9/17/2014)... September 17, 2014 Promising new research ... sheds more light on the potential ability of ketones ... disease dementia. The study shows that ... be caused by impaired glucose uptake and/or utilization, and ... brain function. , The study, by the Research Center ...
(Date:9/17/2014)... 2014) A study led by St. Jude Children,s ... threshold below which male childhood cancer survivors are ... appears in September 17 edition of the journal ... patients are at highest risk for reduced sperm ... eventually increase use of pre-treatment fertility preservation methods ...
(Date:9/17/2014)... leads to an explosion of flavours in your mouth. Researchers ... can mimic what happens in your mouth when you drink ... dryness in the wine. , When wine growers turn their ... processes to bring out the desired flavour in the product ... of the taste is known in wine terminology as astringency, ...
(Date:9/17/2014)... Los Angeles, CA (PRWEB) September 17, 2014 ... Indian news outlet, tells of a 24-year-old man named Advait ... severe back pain caused by degenerative disc disease. This ... putting pressure on his nerve roots and causing severe ... degenerative disc disease and how it can lead to ...
Breaking Medicine News(10 mins):Health News:Vitals Honors Dr. Shervin Naderi With Top 10 Doctor Award 2Health News:Vitals Honors Dr. Shervin Naderi With Top 10 Doctor Award 3Health News:Journal of Alzheimer's Disease Publishes New Study Suggesting Ketones have Potential to Compensate for Brain Energy Deficit 2Health News:Journal of Alzheimer's Disease Publishes New Study Suggesting Ketones have Potential to Compensate for Brain Energy Deficit 3Health News:Improved risk identification will aid fertility preservation in young male cancer patients 2Health News:Improved risk identification will aid fertility preservation in young male cancer patients 3Health News:Nanoscience makes your wine better 2Health News:Nanoscience makes your wine better 3Health News:24-Year-Old Back in College After Degenerative Disc Disease Kept Him Out 2Health News:24-Year-Old Back in College After Degenerative Disc Disease Kept Him Out 3
... reactions to a,prescribed medication send more than 175,000 older ... used medications -- almost all,of them for heart disease ... March 2008 issue of the Harvard Heart Letter offers ... Warfarin: Check your bleeding time (INR) regularly. Take ...
... and Amortization Increased ... 3.85% and 2.96%, Respectively, MEXICO CITY, ... "the Group"), one of the leading Mexican,distributors of pharmaceutical products, ... other products,announces its consolidated financial and operating results for the ...
... is a,statement by William V. Corr, Executive Director, ... restaurants, bars and gaming,facilities, will be smoke-free beginning ... the Legislature last week and signed,into law today ... have delivered a historic victory for public health ...
... West announced today,that one of the country,s most iconic ... The Shops at The Bravern in downtown Bellevue as ... the needs of approximately 2,300,Microsoft employees who will be ... this fall., DavidBartonGym will offer Barton,s world renowned ...
... Over 200,of MemorialCare,s top leaders will participate in ... Habitat for Humanity of Orange County. The,home will be ... cerebral palsy and is confined to a wheelchair. Halls ... will be given a "makeover" with,upgrades throughout., (Photo: ...
... patient acceptance and ... ... that treats acute and chronic constipation, may be an,effective option for ... PEG 3350 products. Marketed in the,U.S. by Cumberland Pharmaceuticals, Kristalose(R) is ...
Cached Medicine News:Health News:Tips for Troublesome Medications, From the Harvard Heart Letter 2Health News:Grupo Casa Saba Announces Fourth Quarter 2007 Results 2Health News:Grupo Casa Saba Announces Fourth Quarter 2007 Results 3Health News:Grupo Casa Saba Announces Fourth Quarter 2007 Results 4Health News:Nebraska's New Smoke-Free Law is Historic Win for Health 2Health News:World-Famous DavidBartonGym Buffs up the Bravern 2Health News:World-Famous DavidBartonGym Buffs up the Bravern 3Health News:MemorialCare Sponsors Habitat for Humanity Santa Ana Home 2Health News:Kristalose(R) Offers Prescription Alternative to MiraLAX(R) and Other PEG 3350 Products 2Health News:Kristalose(R) Offers Prescription Alternative to MiraLAX(R) and Other PEG 3350 Products 3
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: